Other relevant pathways, including ‘MAPK signaling pathway’, ‘ErbB signaling pathway’, ‘Nucleotide excision repair’, ‘DNA replication’, ‘B cell receptor signaling pathway’, ‘mTOR signaling pathway’, and ‘VEGF signaling pathway’ as well as pathways for several more cancers, were enriched in at least 10 experimental sub-networks and control sub-networks. The gene discussed is EGFR; the disease is cancer.